Cytotoxic Activities of Alkylphosphocholines against Clinical Isolates of Acanthamoeba spp
Open Access
- 1 March 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (3) , 695-701
Abstract
Free-living amoebae of the genus Acanthamoeba are causing serious chronic conditions such as destructive keratitis in contact lens wearers or granulomatous amoebic encephalitis in individuals with compromised immune systems. Both are characterized by the lack of availability of sufficiently effective and uncomplicated, manageable treatments. Hexadecylphosphocholine (miltefosine) is licensed for use as a topical antineoplastic agent, but it is also active in vitro against several protozoan parasites, and it was applied very successfully for the treatment of human visceral leishmaniasis. The aim of our study was to evaluate the efficacy of hexadecylphosphocholine and other alkylphosphocholines (APCs) against Acanthamoeba spp. The in vitro activities of eight different APCs against three Acanthamoeba strains of various pathogenicities were determined. All substances showed at least amoebostatic effects, and some of them disrupted the amoebae, as shown by the release of cytoplasmic enzyme activity. Hexadecylphosphocholine exhibited the highest degree of cytotoxicity against trophozoites, resulting in complete cell death at a concentration as low as 40 μM, and also displayed significant cysticidal activity. Hexadecylphosphocholine may be a promising new candidate for the topical treatment of Acanthamoeba keratitis and, conceivably, even for the oral treatment of granulomatous amoebic encephalitis.Keywords
This publication has 31 references indexed in Scilit:
- Effects of Miltefosine and Other Alkylphosphocholines on Human Intestinal Parasite Entamoeba histolyticaAntimicrobial Agents and Chemotherapy, 2001
- Correlations between Morphological, Molecular Biological, and Physiological Characteristics in Clinical and Nonclinical Isolates of Acanthamoeba sppApplied and Environmental Microbiology, 2000
- Miltefosine, an Oral Agent, for the Treatment of Indian Visceral LeishmaniasisNew England Journal of Medicine, 1999
- Treatment of Acanthamoeba keratitis with chlorhexidineOphthalmology, 1999
- Acanthamoeba keratitis: multicentre survey in England 1992-6British Journal of Ophthalmology, 1998
- Acanthamoeba keratitis—Resistance to medical therapyEye, 1990
- Hexadecylphosphocholine: a new and selective antitumor drugCancer Treatment Reviews, 1990
- Hexadecylphosphocholine, a New Ether Lipid Analogue Studies on the Antineoplastic Activity in Vitro and in VivoActa Oncologica, 1989
- Granulomatous brain tumor caused by AcanthamoebaJournal of Neurosurgery, 1986
- Comparative Studies on Related Free‐Living and Pathogenic Amebae With Special Reference to Acanthamoeba*The Journal of Protozoology, 1975